Compared with doxorubicin treatment or MYC depletion alone, combing MYC depletion with doxorubicin treatment greatly blunted tumor growth (Supplementary Fig. 15b) with increased infiltration of macrophages, and enhanced activation of macrophages with M1 phenotype (Supplementary Fig. 15c). This evidence concerns the gene MYC and neoplasm.